Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
10.96
+0.19 (1.76%)
Nov 4, 2024, 4:00 PM EST - Market closed

Addex Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
9711436045
Upgrade
Market Cap Growth
-48.81%-34.64%-74.03%-28.14%34.18%-25.63%
Upgrade
Enterprise Value
52027407
Upgrade
Last Close Price
10.966.0512.60125.80268.00-
Upgrade
PE Ratio
1.91-35.86-25.31-254.88-492.01-
Upgrade
PS Ratio
6.723.757.1912.5013.7215.33
Upgrade
PB Ratio
0.465.402.112.333.641.70
Upgrade
P/FCF Ratio
-0.74-0.77-0.63-2.67-4.35-4.57
Upgrade
P/OCF Ratio
-0.74-0.77-0.63-2.68-4.37-4.58
Upgrade
EV/Sales Ratio
5.001.060.287.769.202.50
Upgrade
EV/EBITDA Ratio
-0.38-0.17-0.02-1.61-3.01-0.49
Upgrade
EV/EBIT Ratio
-0.38-0.17-0.02-1.58-2.92-0.49
Upgrade
EV/FCF Ratio
-0.54-0.22-0.02-1.66-2.92-0.74
Upgrade
Debt / Equity Ratio
0.000.300.080.030.040.02
Upgrade
Debt / FCF Ratio
0.00-0.04-0.02-0.03-0.05-0.06
Upgrade
Asset Turnover
0.080.250.090.150.150.08
Upgrade
Quick Ratio
4.671.392.305.035.185.57
Upgrade
Current Ratio
4.971.462.395.315.385.70
Upgrade
Return on Equity (ROE)
-126.29%-348.48%-190.48%-97.35%-64.08%-45.64%
Upgrade
Return on Assets (ROA)
-61.71%-99.44%-83.22%-45.37%-28.76%-24.26%
Upgrade
Return on Capital (ROIC)
-73.55%-189.67%-113.00%-59.47%-37.10%-27.95%
Upgrade
Earnings Yield
52.47%-170.78%-200.32%-38.95%-24.15%-34.03%
Upgrade
FCF Yield
-98.93%-129.41%-158.28%-37.38%-22.99%-21.90%
Upgrade
Buyback Yield / Dilution
-50.83%-64.45%-32.43%-27.88%-0.96%-13.46%
Upgrade
Total Shareholder Return
-50.83%-64.45%-32.43%-27.88%-0.96%-13.46%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.